Local government intervention slows pharm-emerging economies

05/2/2011 | PharmExec.com

In Turkey and other emerging pharmaceutical markets, governments are taking steps to bolster domestic production, such as by subjecting foreign-made drugs to separate certification inspections that slow the flow of imports, Pharmaceutical Executive magazine editor-in-chief William Looney writes. The average time for a new drug to get marketing approval in Turkey is 772 days, compared with about 200 days in the European Union, according to a trade association.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA